HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Studies on the prekallikrein-bradykininogen system in liver disease.

Abstract
The plasma prekallikrein-bradykininogen system was studied in 45 patients with chronic liver disease since its activation with increased liberation of kinin into the plasma could account for some of the clinical manifestations of cirrhosis, namely, vasodilatation, hypotension, and increased capillary permeability.A significant reduction in plasma bradykininogen was found in the cirrhotic patients as compared with control groups of normal subjects and hospital inpatients. The mean plasma prekallikrein was not significantly different and only five patients with liver disease had reduced levels. The most likely explanation for the low plasma bradykininogen was impairment of synthesis by the cirrhotic liver, the usually normal prekallikrein levels making the other possibility of increased activation of bradykininogen to bradykinin in the plasma less likely.
AuthorsD Stewart, L M Blendis, R Williams
JournalJournal of clinical pathology (J Clin Pathol) Vol. 25 Issue 5 Pg. 410-4 (May 1972) ISSN: 0021-9746 [Print] England
PMID5046072 (Publication Type: Journal Article)
Chemical References
  • Enzyme Precursors
  • Iodine Isotopes
  • Kallikreins
  • Bradykinin
Topics
  • Bradykinin (biosynthesis, blood)
  • Chronic Disease
  • Enzyme Precursors (blood)
  • Hepatitis (blood)
  • Humans
  • Hydrolysis
  • Iodine Isotopes
  • Kallikreins (blood)
  • Liver Cirrhosis (blood)
  • Liver Cirrhosis, Biliary (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: